Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?
- PMID: 33737379
- PMCID: PMC8920038
- DOI: 10.1183/13993003.04077-2020
Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics?
Conflict of interest statement
Conflict of interest: S. Mohamed has nothing to disclose. Conflict of interest: C.U. Köser reports personal fees for consultancy from World Health Organization, TB Alliance, Becton Dickinson, QuantuMDx and Foundation for Innovative New Diagnostics (including work for Cepheid Inc. and Hain Lifescience), other (travel and accommodation support to attend meetings) from Hain Lifescience, other (collaboration) from YD Diagnostics, outside the submitted work; is an unpaid advisor to GenoScreen. Conflict of interest: M. Salfinger has nothing to disclose. Conflict of interest: W. Sougakoff has nothing to disclose. Conflict of interest: S.K. Heysell has nothing to disclose.
Figures
Comment on
-
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.Eur Respir J. 2021 Mar 18;57(3):2002338. doi: 10.1183/13993003.02338-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 32943401 Free PMC article.
References
-
- Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH. List of Prokaryotic Names with Standing in Nomenclature. Genus Mycobacterium. https://lpsn.dsmz.de/genus/mycobacterium Date last accessed: 29 Oct 2020.
-
- Banaei N, Musser KA, Salfinger M, et al. Novel assays/applications for patients suspected of mycobacterial diseases. Clin Lab Med 2020; 40: 535–552. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources